Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03276455 |
|
Recruitment Status : Unknown
Verified September 2017 by Chunfu Li, Nanfang Hospital of Southern Medical University.
Recruitment status was: Not yet recruiting
First Posted : September 8, 2017
Last Update Posted : September 8, 2017
|
Sponsor:
Nanfang Hospital of Southern Medical University
Collaborator:
Guangdong Yike Gene Science and Technology CO.,Ltd
Information provided by (Responsible Party):
Chunfu Li, Nanfang Hospital of Southern Medical University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | September 15, 2020 |
| Estimated Study Completion Date : | September 15, 2021 |